1-3 of 3
Stefan Pursche
Close
Sort by
Journal Articles

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge Trial –

Jan Moritz Middeke, MD, Regina Herbst, MD, Stefani Parmentier, MD, Gesine Bug, MD, PhD, Mathias Hänel, MD, Gernot Stuhler, MD, Kerstin Schäfer-Eckart, MD, Wolf Rösler, MD, Stefan A. Klein, MD, Wolfgang A Bethge, MD, Ulrich Bitz, MD, Nael Alakel, MD, Markus Schaich, MD, Anke Morgner, MD, Stefan Pursche, MD, Michael Kramer, PhD, Uwe Platzbecker, MD, PhD, Christoph Röllig, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD, M. Sc
Journal: Blood
Blood (2013) 122 (21): 304.
https://doi.org/10.1182/blood.V122.21.304.304
Published: 2013
Journal Articles

Side Effects on the Heart and Skeleton of Growing Mice Attributed to Chronic Imatinib Exposure.

Meinolf Suttorp, MD, Julia Boehme, Johannes Vaitl, Birgit Mosch, Stefan Pursche, Roland Jung, Ralf Bergmann, Rainer Fischer, Jens Pietzsch, Martin Bornhaeuser, Juerg A. Gasser
Journal: Blood
Blood (2008) 112 (11): 1100.
https://doi.org/10.1182/blood.V112.11.1100.1100
Published: 2008
Journal Articles

Activity and Induction of Apoptosis of the Specific Tyrosine Kinase Inhibitor AMN 107 in bcr-abl + Cell Lines and in Imatinib Resistant Primary Cells from CML Patients.

Philipp Le Coutre, MD, Gökben Baskaynak, MD, Ingo Tamm, MD, Jörg Westermann, MD, Justus Duyster, MD, Malte v. Bonin, MD, Stefan Pursche, MD, Petra Mayer, MD, Paul Manley, Ph.D., Jürgen Mestan, Ph.D., Eberhard Schleyer, M.D., Bernd Dorken, M.D.
Journal: Blood
Blood (2004) 104 (11): 762.
https://doi.org/10.1182/blood.V104.11.762.762
Published: 2004